Ann: December 2018 Appendix 4C - Quarterly, page-2

Good quarterly update.
The science model progressing nicely.
Imminent commencement of the Ptx-100 trial (s), awaiting collaboration results/finding and current concurrent three trials of the Ptx-200 as scheduled.
The business model on funding is nearing review (IMO).
That is, current funds at 4.2 mil (including tax rebate), yet next quarter estimated at a burn rate of 2.2mil.
Obviously a plausible explanation as to the recent sell down we are/ have witnessed.
So, interesting two quarters re CR requirements...
, let’s hope timing, past mistakes, dilution and holder  value ( not just majors) are on the boards and ceo’s Priorities.
GLTAH